The Japan hemostats market reached USD 220.3 million in 2024 and is projected by IMARC Group to reach USD 362.6 million by 2033, growing at a CAGR of 5.1% from 2025 to 2033. The market is primarily driven by the increasing prevalence of chronic conditions such as cardiovascular diseases, cancer, and diabetes, coupled with a growing demand for surgical interventions. https://www.imarcgroup.com/japan-hemostats-market